Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$150M |
| 2 |
ExxonMobil
XOM
|
+$121M |
| 3 |
Visa
V
|
+$94.9M |
| 4 |
Columbia Banking Systems
COLB
|
+$94.4M |
| 5 |
GE HealthCare
GEHC
|
+$89.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walmart Inc
WMT
|
+$320M |
| 2 |
JPMorgan Chase
JPM
|
+$209M |
| 3 |
Thermo Fisher Scientific
TMO
|
+$96.7M |
| 4 |
GE Aerospace
GE
|
+$89M |
| 5 |
ConocoPhillips
COP
|
+$88.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.82% |
| 2 | Financials | 16.13% |
| 3 | Industrials | 13.26% |
| 4 | Healthcare | 11.06% |
| 5 | Consumer Discretionary | 10.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1676
Teva Pharmaceuticals
TEVA
$40B
| $30.8M | 0.01% |
3,474,863
-96,712
| -3% | -$956K |
|
1677
Byline Bancorp
BY
$1.81B
| $30.7M | 0.01% |
1,421,756
+123,382
| +10% | +$2.88M |
|
1678
Pinduoduo
PDD
$128B
| $30.7M | 0.01% |
403,967
-4,151
| -1% | -$375K |
|
1679
Smith & Wesson
SWBI
$657M
| $30.7M | 0.01% |
2,490,598
+193,438
| +8% | +$2.07M |
|
1680
Intellia Therapeutics
NTLA
$1.51B
| $30.6M | 0.01% |
820,492
-99,584
| -11% | -$3.91M |
|
1681
Lazard
LAZ
$4.2B
| $30.5M | 0.01% |
922,576
-79,277
| -8% | -$2.92M |
|
1682
Titan International
TWI
$466M
| $30.5M | 0.01% |
2,906,220
-35,170
| -1% | -$498K |
|
1683
Vermilion Energy
VET
$1.75B
| $30.5M | 0.01% |
2,347,820
-17,265
| -0.7% | -$243K |
|
1684
Qfin Holdings
QFIN
$1.7B
| $30.4M | 0.01% |
1,565,607
+834
| +0.1% | +$17.5K |
|
1685
American Airlines Group
AAL
$10.6B
| $30.3M | 0.01% |
2,056,438
+152,897
| +8% | +$2.38M |
|
1686
National Vision
EYE
$1.8B
| $30.2M | 0.01% |
1,604,409
+15,350
| +1% | +$500K |
|
1687
Zumiez
ZUMZ
$347M
| $30.2M | 0.01% |
1,638,151
+549
| +0% | +$12.6K |
|
1688
Select Water Solutions
WTTR
$2.31B
| $30.2M | 0.01% |
4,333,273
+686,787
| +19% | +$5.35M |
|
1689
IES Holdings
IESC
$14.3B
| $30.1M | 0.01% |
698,454
-2,964
| -0.4% | -$122K |
|
|
AXNX
1690
DELISTED
Axonics, Inc. Common Stock
AXNX
| $30M | 0.01% |
550,688
+89,029
| +19% | +$5.2M |
|
1691
Nicolet Bankshares
NIC
$3.67B
| $30M | 0.01% |
475,076
+38,925
| +9% | +$2.81M |
|
|
SWI
1692
DELISTED
SolarWinds Corporation Common Stock
SWI
| $29.9M | 0.01% |
3,478,619
+306,694
| +10% | +$2.85M |
|
1693
Compass Minerals
CMP
$1.2B
| $29.9M | 0.01% |
871,071
+288,891
| +50% | +$11.6M |
|
1694
PJT Partners
PJT
$4.35B
| $29.8M | 0.01% |
412,575
+4,124
| +1% | +$317K |
|
1695
Douglas Emmett
DEI
$1.98B
| $29.8M | 0.01% |
2,415,409
+114,039
| +5% | +$1.65M |
|
|
MRC
1696
DELISTED
MRC Global
MRC
| $29.8M | 0.01% |
3,063,800
-70,625
| -2% | -$802K |
|
1697
Sunstone Hotel Investors
SHO
$2.19B
| $29.7M | 0.01% |
3,010,413
+2,792
| +0.1% | +$28.3K |
|
|
KDNY
1698
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $29.7M | 0.01% |
1,284,521
+46,441
| +4% | +$1.11M |
|
|
HONE
1699
DELISTED
HarborOne Bancorp
HONE
| $29.6M | 0.01% |
2,425,874
+175,083
| +8% | +$2.34M |
|
1700
Southern Copper
SCCO
$146B
| $29.6M | 0.01% |
418,400
-5,726
| -1% | -$389K |
|
Similar funds
Dimensional Fund Advisors's Q1 2023 Portfolio in Review
As of Q1 2023, Dimensional Fund Advisors held 3,570 positions worth $297B, up 87,611% from $338M the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Dimensional Fund Advisors's Q1 2023 filing shows 79 new, 2,112 increased, 1,113 reduced and 109 closed positions. Its largest new stake was GE HealthCare: 1,253,762 shares worth $103M. The largest sale was Walmart Inc, an estimated $320M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 12% a quarter earlier, followed by Financials and Industrials.
- Dimensional Fund Advisors's largest Q1 2023 buy was GE HealthCare: 1,253,762 shares worth $103M.
- Dimensional Fund Advisors added most to Apple in Q1 2023, an estimated $150M increase.
- Dimensional Fund Advisors's biggest Q1 2023 reduction was Walmart Inc, cutting an estimated $320M.
- Dimensional Fund Advisors fully exited Dimensional Emerging Markets Sustainability Core 1 ETF in Q1 2023, selling an estimated $11.3M.
- Dimensional Fund Advisors's ten largest holdings make up 11% of its $297B portfolio in Q1 2023.
- Dimensional Fund Advisors opened 79 new positions and closed 109 in Q1 2023.
- Dimensional Fund Advisors's portfolio value rose 87,611% quarter-over-quarter to $297B.
Based on Dimensional Fund Advisors's 13F filing for Q1 2023, filed 12 May 2023.